Myofibroblasts: Trust your heart and let fate decide

Journal of Molecular and Cellular Cardiology

Volumn 70, Issue , 2014, Pages 9-18

  Davis, Jennifer ^a   Molkentin, Jeffery D ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Angiotensin II; Extracellular matrix; Fibrosis; Serum response factor; TGF ; TRP channel

Indexed keywords

ACTA2 PROTEIN, HUMAN; ACTIN; ANGIOTENSIN II; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; SERUM RESPONSE FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART; HUMAN; MECHANOTRANSDUCTION; METABOLISM; MYOFIBROBLAST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTINS; ANGIOTENSIN II; CELL DIFFERENTIATION; ENDOTHELIN-1; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION REGULATION; HEART; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MITOGEN-ACTIVATED PROTEIN KINASES; MYOFIBROBLASTS; SERUM RESPONSE FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 84898833444     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.10.019     Document Type: Review

References (163)

1. Bruder O., Wagner A., Jensen C.J., Schneider S., Ong P., Kispert E.M., et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:875-887.
2. O'Hanlon R., Grasso A., Roughton M., Moon J.C., Clark S., Wage R., et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:867-874.
3. Harris K.M., Spirito P., Maron M.S., Zenovich A.G., Formisano F., Lesser J.R., et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006, 114:216-225.
4. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007, 74:207-212.
5. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007, 170:1807-1816.
6. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 2010, 225:631-637.
7. Turner N.A., Porter K.E. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 2013, 6:5.
8. Banerjee I., Yekkala K., Borg T.K., Baudino T.A. Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann N Y Acad Sci 2006, 1080:76-84.
9. Sun Y., Weber K.T. Infarct scar: a dynamic tissue. Cardiovasc Res 2000, 46:250-256.
10. Willems I.E., Havenith M.G., De Mey J.G., Daemen M.J. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 1994, 145:868-875.
11. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008, 12:22-37.
12. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007, 127:526-537.
13. Shiojima I., Aikawa M., Suzuki J., Yazaki Y., Nagai R. Embryonic smooth muscle myosin heavy chain SMemb is expressed in pressure-overloaded cardiac fibroblasts. Jpn Heart J 1999, 40:803-818.
14. Serini G., Bochaton-Piallat M.L., Ropraz P., Geinoz A., Borsi L., Zardi L., et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998, 142:873-881.
15. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363.
16. Desmouliere A., Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines. Cell Motil Cytoskeleton 1994, 29:195-203.
17. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech 2010, 43:146-155.
18. Lazard D., Sastre X., Frid M.G., Glukhova M.A., Thiery J.P., Koteliansky V.E. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A 1993, 90:999-1003.
19. Qiu P., Feng X.H., Li L. Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation. J Mol Cell Cardiol 2003, 35:1407-1420.
20. Sappino A.P., Schurch W., Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990, 63:144-161.
21. Gabbiani G. The biology of the myofibroblast. Kidney Int 1992, 41:530-532.
22. Rice N.A., Leinwand L.A. Skeletal myosin heavy chain function in cultured lung myofibroblasts. J Cell Biol 2003, 163:119-129.
23. Frangogiannis N.G., Michael L.H., Entman M.L. Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 2000, 48:89-100.
24. Hinz B., Pittet P., Smith-Clerc J., Chaponnier C., Meister J.J. Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell 2004, 15:4310-4320.
25. Davis J., Burr A.R., Davis G.F., Birnbaumer L., Molkentin J.D. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell 2012, 23:705-715.
26. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
27. Leeb S.N., Vogl D., Falk W., Scholmerich J., Rogler G., Gelbmann C.M. Regulation of migration of human colonic myofibroblasts. Growth Factors 2002, 20:81-91.
28. Lenga Y., Koh A., Perera A.S., McCulloch C.A., Sodek J., Zohar R. Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008, 102:319-327.
29. Suganuma H., Sato A., Tamura R., Chida K. Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax 1995, 50:984-989.
30. van den Borne S.W., Isobe S., Verjans J.W., Petrov A., Lovhaug D., Li P., et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol 2008, 52:2017-2028.
31. Weber K.T. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts. J Hypertens 2004, 22:47-50.
32. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 2013, 10:15-26.
33. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.
34. Desmouliere A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66.
35. Kissin E., Korn J.H. Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis. Curr Rheumatol Rep 2002, 4:129-135.
36. Takemura G., Ohno M., Hayakawa Y., Misao J., Kanoh M., Ohno A., et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 1998, 82:1130-1138.
37. Jelaska A., Korn J.H. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J Cell Physiol 1998, 175:19-29.
38. Jelaska A., Korn J.H. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum 2000, 43:2230-2239.
39. Zhang H.Y., Phan S.H. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999, 21:658-665.
40. Horowitz J.C., Lee D.Y., Waghray M., Keshamouni V.G., Thomas P.E., Zhang H., et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 2004, 279:1359-1367.
41. Funayama E., Chodon T., Oyama A., Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. J Invest Dermatol 2003, 121:1326-1331.
42. Horowitz J.C., Rogers D.S., Sharma V., Vittal R., White E.S., Cui Z., et al. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 2007, 19:761-771.
43. Wang H., Haeger S.M., Kloxin A.M., Leinwand L.A., Anseth K.S. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One 2012, 7:e39969.
44. Kisseleva T., Cong M., Paik Y., Scholten D., Jiang C., Benner C., et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A 2012, 109:9448-9453.
45. Bataller R., Brenner D.A. Liver fibrosis. J Clin Invest 2005, 115:209-218.
46. Li Y., Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002, 161:895-907.
47. Sato K., Li Y., Foster W., Fukushima K., Badlani N., Adachi N., et al. Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 2003, 28:365-372.
48. Scotton C.J., Chambers R.C. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132:1311-1321.
49. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210.
50. Diez J., Querejeta R., Lopez B., Gonzalez A., Larman M., Martinez Ubago J.L. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512-2517.
51. Brand-Saberi B., Christ B. Evolution and development of distinct cell lineages derived from somites. Curr Top Dev Biol 2000, 48:1-42.
52. Hay E.D., Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995, 26:678-690.
53. Lang H., Fekete D.M. Lineage analysis in the chicken inner ear shows differences in clonal dispersion for epithelial, neuronal, and mesenchymal cells. Dev Biol 2001, 234:120-137.
54. Maric M., Chen L., Sherry B., Liu Y. A mechanism for selective recruitment of CD8 T cells into B7-1-transfected plasmacytoma: role of macrophage-inflammatory protein 1alpha. J Immunol 1997, 159:360-368.
55. Ogawa M., LaRue A.C., Drake C.J. Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood 2006, 108:2893-2896.
56. Chang H.Y., Chi J.T., Dudoit S., Bondre C., van de Rijn M., Botstein D., et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002, 99:12877-12882.
57. Rinn J.L., Bondre C., Gladstone H.B., Brown P.O., Chang H.Y. Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2006, 2:e119.
58. Zeisberg E.M., Kalluri R. Origins of cardiac fibroblasts. Circ Res 2010, 107:1304-1312.
59. Lie-Venema H., van den Akker N.M., Bax N.A., Winter E.M., Maas S., Kekarainen T., et al. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. Sci World J 2007, 7:1777-1798.
60. Acharya A., Baek S.T., Huang G., Eskiocak B., Goetsch S., Sung C.Y., et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139:2139-2149.
61. Dettman R.W., Denetclaw W., Ordahl C.P., Bristow J. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 1998, 193:169-181.
62. Mikawa T., Gourdie R.G. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 1996, 174:221-232.
63. Winter E.M., Gittenberger-de Groot A.C. Epicardium-derived cells in cardiogenesis and cardiac regeneration. Cell Mol Life Sci 2007, 64:692-703.
64. Crawford J.R., Haudek S.B., Cieslik K.A., Trial J., Entman M.L. Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts. J Cardiovasc Transl Res 2012, 5:749-759.
65. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmouliere A., Varga J., et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012, 180:1340-1355.
66. Biernacka A., Frangogiannis N.G. Aging and Cardiac Fibrosis. Aging Dis 2011, 2:158-173.
67. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 2010, 106:1675-1680.
68. Walker G.A., Masters K.S., Shah D.N., Anseth K.S., Leinwand L.A. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004, 95:253-260.
69. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007, 74:184-195.
70. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001, 12:2730-2741.
71. Phan S.H. Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 2008, 5:334-337.
72. Zhang H.Y., Gharaee-Kermani M., Zhang K., Karmiol S., Phan S.H. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 1996, 148:527-537.
73. Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 2009, 11:120-126.
74. Derynck R., Zhang Y.E. SMAD-dependent and SMAD-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
75. Verrecchia F., Chu M.L., Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001, 276:17058-17062.
76. Dobaczewski M., Bujak M., Li N., Gonzalez-Quesada C., Mendoza L.H., Wang X.F., et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res 2010, 107:418-428.
77. Hu B., Wu Z., Liu T., Ullenbruch M.R., Jin H., Phan S.H. Gut-enriched Kruppel-like factor interaction with Smad3 inhibits myofibroblast differentiation. Am J Respir Cell Mol Biol 2007, 36:78-84.
78. Zhao J., Shi W., Wang Y.L., Chen H., Bringas P., Datto M.B., et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:L585-L593.
79. Koitabashi N., Danner T., Zaiman A.L., Pinto Y.M., Rowell J., Mankowski J., et al. Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 2011, 121:2301-2312.
80. Meyer-Ter-Vehn T., Gebhardt S., Sebald W., Buttmann M., Grehn F., Schlunck G., et al. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 2006, 47:1500-1509.
81. Sousa A.M., Liu T., Guevara O., Stevens J., Fanburg B.L., Gaestel M., et al. Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. J Cell Biochem 2007, 100:1581-1592.
82. Wang L., Ma R., Flavell R.A., Choi M.E. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 2002, 277:47257-47262.
83. Wang J., Seth A., McCulloch C.A. Force regulates smooth muscle actin in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2000, 279:H2776-H2785.
84. Kompa A.R., See F., Lewis D.A., Adrahtas A., Cantwell D.M., Wang B.H., et al. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. J Pharmacol Exp Ther 2008, 325:741-750.
85. Matsuoka H., Arai T., Mori M., Goya S., Kida H., Morishita H., et al. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2002, 283:L103-L112.
86. See F., Thomas W., Way K., Tzanidis A., Kompa A., Lewis D., et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 2004, 44:1679-1689.
87. Stambe C., Atkins R.C., Tesch G.H., Masaki T., Schreiner G.F., Nikolic-Paterson D.J. The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 2004, 15:370-379.
88. Stambe C., Nikolic-Paterson D.J., Hill P.A., Dowling J., Atkins R.C. p38 mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol 2004, 15:326-336.
89. Haudek S.B., Cheng J., Du J., Wang Y., Hermosillo-Rodriguez J., Trial J., et al. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 2010, 49:499-507.
90. Shibasaki Y., Nishiue T., Masaki H., Tamura K., Matsumoto N., Mori Y., et al. Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res 2005, 28:787-795.
91. Campbell S.E., Katwa L.C. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 1997, 29:1947-1958.
92. Gray M.O., Long C.S., Kalinyak J.E., Li H.T., Karliner J.S. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998, 40:352-363.
93. Lee A.A., Dillmann W.H., McCulloch A.D., Villarreal F.J. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995, 27:2347-2357.
94. Gao X., He X., Luo B., Peng L., Lin J., Zuo Z. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Eur J Pharmacol 2009, 606:115-120.
95. Rodriguez-Vita J., Sanchez-Lopez E., Esteban V., Ruperez M., Egido J., Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 2005, 111:2509-2517.
96. Yang F., Chung A.C., Huang X.R., Lan H.Y. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3. Hypertension 2009, 54:877-884.
97. Hautmann M.B., Thompson M.M., Swartz E.A., Olson E.N., Owens G.K. Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res 1997, 81:600-610.
98. Abraham D.J., Vancheeswaran R., Dashwood M.R., Rajkumar V.S., Pantelides P., Xu S.W., et al. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol 1997, 151:831-841.
99. Rockey D.C., Chung J.J. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996, 98:1381-1388.
100. Teder P., Noble P.W. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 2000, 23:7-10.
101. Shao R., Shi Z., Gotwals P.J., Koteliansky V.E., George J., Rockey D.C. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Biol Cell 2003, 14:2327-2341.
102. Appleton I., Tomlinson A., Chander C.L., Willoughby D.A. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab Invest 1992, 67:703-710.
103. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994, 124:401-404.
104. Guidry C., Hook M. Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts. J Cell Biol 1991, 115:873-880.
105. Shi-Wen X., Chen Y., Denton C.P., Eastwood M., Renzoni E.A., Bou-Gharios G., et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 2004, 15:2707-2719.
106. Nishida M., Onohara N., Sato Y., Suda R., Ogushi M., Tanabe S., et al. Galpha12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J Biol Chem 2007, 282:23117-23128.
107. Cheng T.H., Cheng P.Y., Shih N.L., Chen I.B., Wang D.L., Chen J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 2003, 42:1845-1854.
108. Shi-Wen X., Rodriguez-Pascual F., Lamas S., Holmes A., Howat S., Pearson J.D., et al. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol 2006, 26:5518-5527.
109. Shi-wen X., Kennedy L., Renzoni E.A., Bou-Gharios G., du Bois R.M., Black C.M., et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 2007, 56:4189-4194.
110. Miano J.M. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003, 35:577-593.
111. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 2010, 107:294-304.
112. Sun Q., Chen G., Streb J.W., Long X., Yang Y., Stoeckert C.J., et al. Defining the mammalian CArGome. Genome Res 2006, 16:197-207.
113. Zhang S.X., Garcia-Gras E., Wycuff D.R., Marriot S.J., Kadeer N., Yu W., et al. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J Biol Chem 2005, 280:19115-19126.
114. Herring B.P., Smith A.F. Telokin expression in A10 smooth muscle cells requires serum response factor. Am J Physiol 1997, 272:C1394-C1404.
115. Johnson R.J., Floege J., Yoshimura A., Iida H., Couser W.G., Alpers C.E. The activated mesangial cell: a glomerular "myofibroblast"?. J Am Soc Nephrol 1992, 2:S190-S197.
116. Mack C.P., Owens G.K. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res 1999, 84:852-861.
117. Mack C.P., Somlyo A.V., Hautmann M., Somlyo A.P., Owens G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 2001, 276:341-347.
118. Mack C.P., Thompson M.M., Lawrenz-Smith S., Owens G.K. Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res 2000, 86:221-232.
119. Miano J.M., Ramanan N., Georger M.A., de Mesy Bentley K.L., Emerson R.L., Balza R.O., et al. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A 2004, 101:17132-17137.
120. Yang Y., Zhe X., Phan S.H., Ullenbruch M., Schuger L. Involvement of serum response factor isoforms in myofibroblast differentiation during bleomycin-induced lung injury. Am J Respir Cell Mol Biol 2003, 29:583-590.
121. Chai J., Norng M., Tarnawski A.S., Chow J. A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats. Gut 2007, 56:621-630.
122. Miralles F., Posern G., Zaromytidou A.I., Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003, 113:329-342.
123. Posern G., Treisman R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 2006, 16:588-596.
124. Sandbo N., Lau A., Kach J., Ngam C., Yau D., Dulin N.O. Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-beta. Am J Physiol Lung Cell Mol Physiol 2011, 301:L656-L666.
125. Mack C.P. Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 2011, 31:1495-1505.
126. Akhmetshina A., Dees C., Pileckyte M., Szucs G., Spriewald B.M., Zwerina J., et al. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts. Arthritis Rheum 2008, 58:2553-2564.
127. Small E.M. The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J Cardiovasc Transl Res 2012, 5:794-804.
128. Herrmann J., Haas U., Gressner A.M., Weiskirchen R. TGF-beta up-regulates serum response factor in activated hepatic stellate cells. Biochim Biophys Acta 2007, 1772:1250-1257.
129. Hirschi K.K., Lai L., Belaguli N.S., Dean D.A., Schwartz R.J., Zimmer W.E. Transforming growth factor-beta induction of smooth muscle cell phenotype requires transcriptional and post-transcriptional control of serum response factor. J Biol Chem 2002, 277:6287-6295.
130. Adapala R.K., Thoppil R.J., Luther D.J., Paruchuri S., Meszaros J.G., Chilian W.M., et al. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol 2013, 54:45-52.
131. Du J., Xie J., Zhang Z., Tsujikawa H., Fusco D., Silverman D., et al. TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res 2010, 106:992-1003.
132. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 2006, 116:3114-3126.
133. Bataller R., Gasull X., Gines P., Hellemans K., Gorbig M.N., Nicolas J.M., et al. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 2001, 33:956-962.
134. Cobbs S.L., Gooch J.L. NFATc is required for TGFbeta-mediated transcriptional regulation of fibronectin. Biochem Biophys Res Commun 2007, 362:288-294.
135. Gooch J.L., Gorin Y., Zhang B.X., Abboud H.E. Involvement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular matrix accumulation. J Biol Chem 2004, 279:15561-15570.
136. Herum K.M., Lunde I.G., Skrbic B., Florholmen G., Behmen D., Sjaastad I., et al. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol 2013, 54:73-81.
137. Gonzalez Bosc L.V., Layne J.J., Nelson M.T., Hill-Eubanks D.C. Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an alpha-actin intronic enhancer. J Biol Chem 2005, 280:26113-26120.
138. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999, 154:871-882.
139. Chen J.H., Chen W.L., Sider K.L., Yip C.Y., Simmons C.A. Beta-catenin mediates mechanically regulated, transforming growth factor-beta1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol 2011, 31:590-597.
140. Goffin J.M., Pittet P., Csucs G., Lussi J.W., Meister J.J., Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J Cell Biol 2006, 172:259-268.
141. Huang X., Yang N., Fiore V.F., Barker T.H., Sun Y., Morris S.W., et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol 2012, 47:340-348.
142. Li Z., Dranoff J.A., Chan E.P., Uemura M., Sevigny J., Wells R.G. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 2007, 46:1246-1256.
143. Liu F., Mih J.D., Shea B.S., Kho A.T., Sharif A.S., Tager A.M., et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol 2010, 190:693-706.
144. Olsen A.L., Bloomer S.A., Chan E.P., Gaca M.D., Georges P.C., Sackey B., et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol 2011, 301:G110-G118.
145. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007, 179:1311-1323.
146. Hinz B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol 2006, 85:175-181.
147. Galie P.A., Westfall M.V., Stegemann J.P. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices. Cardiovasc Pathol 2011, 20:325-333.
148. Provenzano P.P., Keely P.J. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 2011, 124:1195-1205.
149. Gomis A., Soriano S., Belmonte C., Viana F. Hypoosmotic- and pressure-induced membrane stretch activate TRPC5 channels. J Physiol 2008, 586:5633-5649.
150. Spassova M.A., Hewavitharana T., Xu W., Soboloff J., Gill D.L. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci U S A 2006, 103:16586-16591.
151. Vennekens R. Emerging concepts for the role of TRP channels in the cardiovascular system. J Physiol 2011, 589:1527-1534.
152. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
153. Ko K.S., Arora P.D., McCulloch C.A. Cadherins mediate intercellular mechanical signaling in fibroblasts by activation of stretch-sensitive calcium-permeable channels. J Biol Chem 2001, 276:35967-35977.
154. Doyle J.J., Gerber E.E., Dietz H.C. Matrix-dependent perturbation of TGFbeta signaling and disease. FEBS Lett 2012, 586:2003-2015.
155. Heydemann A., Ceco E., Lim J.E., Hadhazy M., Ryder P., Moran J.L., et al. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest 2009, 119:3703-3712.
156. Flanigan K.M., Ceco E., Lamar K.M., Kaminoh Y., Dunn D.M., Mendell J.R., et al. LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy. Ann Neurol 2012, 73:481-488.
157. Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352:337-339.
158. Holm T.M., Habashi J.P., Doyle J.J., Bedja D., Chen Y., van Erp C., et al. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 2011, 332:358-361.
159. Zhao X.H., Laschinger C., Arora P., Szaszi K., Kapus A., McCulloch C.A. Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J Cell Sci 2007, 120:1801-1809.
160. Wang R., Clark R.A., Mosher D.F., Ren X.D. Fibronectin's central cell-binding domain supports focal adhesion formation and Rho signal transduction. J Biol Chem 2005, 280:28803-28810.
161. Wang J., Fan J., Laschinger C., Arora P.D., Kapus A., Seth A., et al. Smooth muscle actin determines mechanical force-induced p38 activation. J Biol Chem 2005, 280:7273-7284.
162. Zhou Y., Huang X., Hecker L., Kurundkar D., Kurundkar A., Liu H., et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest 2013, 123:1096-1108.
163. Wang J., Zohar R., McCulloch C.A. Multiple roles of alpha-smooth muscle actin in mechanotransduction. Exp Cell Res 2006, 312:205-214.